These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

270 related items for PubMed ID: 32503471

  • 21. Clozapine-induced neutropenia in children: management with lithium carbonate.
    Sporn A, Gogtay N, Ortiz-Aguayo R, Alfaro C, Tossell J, Lenane M, Gochman P, Rapoport JL.
    J Child Adolesc Psychopharmacol; 2003; 13(3):401-4. PubMed ID: 14642024
    [Abstract] [Full Text] [Related]

  • 22. Reversible neutropenia with olanzapine following clozapine-induced neutropenia.
    Thangadurai P, Jyothi KS, Gopalakrishnan R, Kuruvilla A, Jacob KS.
    Am J Psychiatry; 2006 Jul; 163(7):1298. PubMed ID: 16816247
    [No Abstract] [Full Text] [Related]

  • 23. As-Required Filgrastim for Late-Onset Neutropenia Complicating Long-Term Clozapine Treatment: a Case Report.
    Chan KSW, Lai NBW, Wong MMC, Pang PF.
    East Asian Arch Psychiatry; 2023 Mar; 33(1):28-31. PubMed ID: 36991553
    [Abstract] [Full Text] [Related]

  • 24. Clozapine rechallenge or continuation despite neutropenia or agranulocytosis using colony-stimulating factor: A systematic review.
    Corbeil O, Béchard L, Fournier É, Plante M, Thivierge MA, Lafrenière CÉ, Huot-Lavoie M, Brodeur S, Essiambre AM, Roy MA, Demers MF.
    J Psychopharmacol; 2023 Apr; 37(4):370-377. PubMed ID: 36794520
    [Abstract] [Full Text] [Related]

  • 25. Clozapine-induced agranulocytosis in Japan: Changes in leukocyte/neutrophil counts before and after discontinuation of clozapine.
    Matsui K, Ishibashi M, Kawano M, Oshibuchi H, Ishigooka J, Nishimura K, Inada K.
    Hum Psychopharmacol; 2020 Jul; 35(4):e2739. PubMed ID: 32420645
    [Abstract] [Full Text] [Related]

  • 26. Lithium and clozapine rechallenge: a retrospective case analysis.
    Kanaan RA, Kerwin RW.
    J Clin Psychiatry; 2006 May; 67(5):756-60. PubMed ID: 16841625
    [Abstract] [Full Text] [Related]

  • 27. Severe clozapine-induced agranulocytosis: successful treatment with G-CSF and rechallenge of clozapine plus D2 potentiation therapy (amisulpride).
    Ruiz-Doblado S, Plasencia-García de Diego B, Perea-Pérez R, Jiménez-Gonzalo F.
    Actas Esp Psiquiatr; 2020 Mar; 48(2):89-91. PubMed ID: 32463914
    [No Abstract] [Full Text] [Related]

  • 28. Blood dyscrasias in clozapine-treated patients in Italy.
    Lambertenghi Deliliers G.
    Haematologica; 2000 Mar; 85(3):233-7. PubMed ID: 10702809
    [Abstract] [Full Text] [Related]

  • 29. Clozapine and concomitant chemotherapy in a patient with schizophrenia and new onset esophageal cancer.
    Monga V, Broucek M, Amani M, Ramaswamy S.
    Psychooncology; 2015 Aug; 24(8):971-2. PubMed ID: 25644505
    [No Abstract] [Full Text] [Related]

  • 30. The Use of Granulocyte Colony-Stimulating Factor in Clozapine Rechallenge: A Systematic Review.
    Lally J, Malik S, Krivoy A, Whiskey E, Taylor DM, Gaughran FP, Flanagan RJ, Mijovic A, MacCabe JH.
    J Clin Psychopharmacol; 2017 Oct; 37(5):600-604. PubMed ID: 28817489
    [Abstract] [Full Text] [Related]

  • 31. Treatment of severe clozapine-induced neutropenia with granulocyte colony-stimulating factor (G-CSF). Remission despite continuous treatment with clozapine.
    Sperner-Unterweger B, Czeipek I, Gaggl S, Geissler D, Spiel G, Fleischhacker WW.
    Br J Psychiatry; 1998 Jan; 172():82-4. PubMed ID: 9534838
    [Abstract] [Full Text] [Related]

  • 32. Clozapine, agranulocytosis, and benign ethnic neutropenia.
    Rajagopal S.
    Postgrad Med J; 2005 Sep; 81(959):545-6. PubMed ID: 16143678
    [No Abstract] [Full Text] [Related]

  • 33. Clozapine Rechallenge After Major Adverse Effects: Clinical Guidelines Based on 259 Cases.
    Manu P, Lapitskaya Y, Shaikh A, Nielsen J.
    Am J Ther; 2018 Sep; 25(2):e218-e223. PubMed ID: 29505490
    [Abstract] [Full Text] [Related]

  • 34. Clozapine-associated severe eosinophilia following lithium rebound neutropenia: A case report.
    Kikuchi K, Yasui-Furukori N, Yokoyama S, Hasegawa C, Kokubun A, Katsukura S, Shimizu T, Shimoda K.
    Neuropsychopharmacol Rep; 2020 Dec; 40(4):388-391. PubMed ID: 32951324
    [Abstract] [Full Text] [Related]

  • 35. Circadian rhythm of white blood cells during clozapine treatment.
    Ahokas A, Elonen E.
    Psychopharmacology (Berl); 1999 Jun; 144(3):301-2. PubMed ID: 10435399
    [Abstract] [Full Text] [Related]

  • 36. Clozapine Rechallenge or Continuation Despite Neutropenia, an Extended Follow-up of a Consecutive Quebec Case Series.
    Béchard L, Morasse-Bégis M, Corbeil O, Hakim JR, Malenfant E, Brodeur S, Huot-Lavoie M, Essiambre AM, Demers MF, Roy MA.
    J Clin Psychopharmacol; 1999 Jun; 42(4):391-395. PubMed ID: 35546087
    [Abstract] [Full Text] [Related]

  • 37. Long-term sustained benefits of clozapine treatment in refractory early onset schizophrenia: a retrospective study in Korean children and adolescents.
    Kim Y, Kim BN, Cho SC, Kim JW, Shin MS.
    Hum Psychopharmacol; 2008 Dec; 23(8):715-22. PubMed ID: 18814190
    [Abstract] [Full Text] [Related]

  • 38. Evaluating the Effect of the Changes in FDA Guidelines for Clozapine Monitoring.
    Sultan RS, Olfson M, Correll CU, Duncan EJ.
    J Clin Psychiatry; 2017 Dec; 78(8):e933-e939. PubMed ID: 28742291
    [Abstract] [Full Text] [Related]

  • 39. Optimizing outcomes in clozapine rechallenge following neutropenia using human leukocyte antigen typing: A case report.
    Yamaki N, Hishimoto A, Otsuka I, Sasada T, Boku S, Saito T, Yasuda Y, Yamamori H, Ikeda M, Ikeda M, Sora I, Iwata N, Hashimoto R.
    Psychiatry Clin Neurosci; 2017 Apr; 71(4):289-290. PubMed ID: 28097743
    [No Abstract] [Full Text] [Related]

  • 40. Neutropenia and Agranulocytosis in Chinese Patients Prescribed Clozapine.
    Lau KL, Yim PH.
    East Asian Arch Psychiatry; 2015 Dec; 25(4):164-7. PubMed ID: 26764291
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 14.